Amanda Dydynski is the Director of Investment Banking (Health Sciences) at Crosstree, based in the United States. She joined Crosstree in October 2023.

Prior to her current role, Amanda served as Director of Investment Banking (Healthcare Life Sciences) at KPMG Corporate Finance LLC from October 2020 to September 2023.

Before KPMG, she held the position of Vice President of Investment Banking (Healthcare Life Sciences) at KPMG Corporate Finance LLC from December 2015 to September 2020.

Amanda's earlier experience includes working as a Commercial Strategy & Research Partner (Pharma) at Bayer from October 2014 to December 2015, and as an Investment Research Analyst (Healthcare) at Imperial Capital Group Ltd. from January 2013 to January 2014.

She also served as a Business Development Analyst (Cell and Gene Therapy) at the Centre for Commercialization of Regenerative Medicine (CCRM) from January 2012 to January 2013.